Madrigal Pharmaceuticals Long Term Deferred Assets (Quarterly) Insights

Madrigal Pharmaceuticals, Inc. (MDGL)

435.01 -1.86 (-0.43%) USD | NASDAQ | Feb 20, 16:00

435.20 +0.19 (+0.04%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for MDGL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Pfizer Inc.	Upgrade
Eli Lilly & Co.	Upgrade
Insmed, Inc.	--
Johnson & Johnson	Upgrade
Crinetics Pharmaceuticals, Inc.	--